Quanta

Server Supply Chain Becomes Fragmented, ODM’s Southeast Asia SMT Capacity Expected to Account for 23% in 2023, Says TrendForce

Retrieved on: 
Wednesday, August 23, 2023
Technology, Manufacturing, Alternative Energy, Energy, Transport, Environment, Sustainability, Software, Networks, Other Manufacturing, Semiconductor, Data Management, Security, Logistics, Supply Chain Management, Graphics processing unit, ODM, Meta, Table, Microsoft, Central processing unit, SMT, TPU, Foxconn, CPU, Intel, AI, AWS, Celestica, Video game, Quanta, Inventec, Metaverse, Wistron

US-based CSPs have been establishing SMT production lines in Southeast Asia since late 2022 to mitigate geopolitical risks and supply chain disruptions.

Key Points: 
  • US-based CSPs have been establishing SMT production lines in Southeast Asia since late 2022 to mitigate geopolitical risks and supply chain disruptions.
  • It’s projected that by 2023, the production capacity from these regions will account for 23%, and by 2026, it will approach 50%.
  • Meanwhile, Foxconn has renovated its existing facilities in Hanoi, Vietnam and uses its Wisconsin plant to accommodate customer needs.
  • Inventec’s current strategy mirrors that of Quanta, with plans to build SMT production lines in Thailand by 2024 and commence server production in late 2024.

Quanta™ Announces Enrollment Completion in Home Run Study

Retrieved on: 
Thursday, August 17, 2023
Quanta, FASN, Kidney disease, FRCPC, FDA, Home run, Patient, MHA, Safety, Medical device

BEVERLY, Mass., Aug. 17, 2023 /PRNewswire/ -- Quanta Dialysis Technologies® today announced that it has completed enrollment of its Home Run study for at-home hemodialysis. The Home Run study is a prospective, multi-center, open-label trial to assess the efficacy and safety of the Quanta Dialysis System for home hemodialysis. Results are expected to be announced in the second half of 2023.

Key Points: 
  • BEVERLY, Mass., Aug. 17, 2023 /PRNewswire/ -- Quanta Dialysis Technologies® today announced that it has completed enrollment of its Home Run study for at-home hemodialysis.
  • The Home Run study is a prospective, multi-center, open-label trial to assess the efficacy and safety of the Quanta Dialysis System for home hemodialysis.
  • Results are expected to be announced in the second half of 2023.
  • Enrollment completion is the first step forward in a potential new alternative for people with this life-threatening disease."

KORE Power Announces Major Offtake Agreement with Energy Vault for Domestic Batteries Starting in 2025

Retrieved on: 
Wednesday, August 9, 2023
Environment, Other Energy, Chemicals, Plastics, Environmental Health, Utilities, Manufacturing, Alternative Energy, Sustainability, Energy, Quanta, Siemens Financial Services, Senior, Quanta Services, U.S. Department of Defense Strategy for Operating in Cyberspace, KORE, Energy Vault, LFP, LPO, Advanced Technology Vehicles Manufacturing Loan Program, Cell, NMC, Economics, IRA, Honeywell, Kilowatt-hour, ATVM, News, Corporate development, Electric battery, Renewable energy

KORE Power, Inc. (KORE) has been selected by Energy Vault to deliver domestically produced batteries starting in 2025, when phase one of the KOREPlex facility in Arizona comes online.

Key Points: 
  • KORE Power, Inc. (KORE) has been selected by Energy Vault to deliver domestically produced batteries starting in 2025, when phase one of the KOREPlex facility in Arizona comes online.
  • In the first phase of the agreement with Energy Vault, KORE Power will manufacture the batteries at its KOREPlex facility in Buckeye, AZ.
  • “Energy Vault sought a strategic domestic battery manufacturing partner that would provide an advantage to our grid-scale energy storage solution customers,” said Marco Terruzzin, Chief Commercial & Product Officer, Energy Vault.
  • “We see KORE Power leading the way as one of the first independent domestic manufacturers,” said Kevin Keough, Senior Vice President of Corporate Development, Energy Vault.

Quanta™ Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies

Retrieved on: 
Thursday, August 3, 2023
Quanta, IHD, Biochemistry, SLED, Nursing, Hospital, Food and Drug Administration, Mortality, AKI, Dialysis, Kidney disease, Acute kidney injury, CRRT, Nephrology, Patient, FASN, Hemofiltration, ICU, FRCPC, ESKD, TKT, FDA, Society, MHA, Food, Software, Medical device

BEVERLY, Mass., Aug. 3, 2023 /PRNewswire/ -- Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device, for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF). Under the new 510(k), the Quanta Dialysis System is the only dialysis device FDA-cleared to provide intermittent hemodialysis (IHD), sustained low efficiency dialysis (SLED) or bagless CRRT which creates dialysate on demand – all in a single machine.

Key Points: 
  • The Quanta Dialysis System is the only dialysis device FDA-cleared to perform IHD, SLED or CRRT - all in a one platform.
  • The Quanta Dialysis System was originally designed to serve the more than two million people with end-stage kidney disease (ESKD) worldwide who receive treatment with dialysis or a kidney transplant.
  • It features dialysate flow rates from 50 to 500 mL/min and treatment times up to 24 hours of continuous delivery.
  • "This clearance is a true game-changer for acute care settings," said Quanta Chief Executive Officer, Alejandro Galindo.

Quanta Services Named 2023 Top Solar Contractor by Solar Power World

Retrieved on: 
Tuesday, July 25, 2023
Powerhouse, Ryan Companies, Quanta Services, Electricity, EPC, History, Wind, Public sector, PWR, RPCS, NYSE, Renewable energy, Quanta, Blattner

HOUSTON, July 25, 2023 /PRNewswire/ -- Quanta Services, Inc. (NYSE:PWR) announced today that it has been named the top solar infrastructure solutions provider in the United States by Solar Power World. This achievement was made possible by the collaborative work of three Quanta operating companies: Blattner Company, RP Construction Services (RPCS) and The Ryan Company. The combined expertise and efforts of the three companies installed more than two gigawatts of domestic solar generating capacity in 2022 alone – a new milestone of achievement in Top Solar Contractor history.

Key Points: 
  • HOUSTON, July 25, 2023 /PRNewswire/ -- Quanta Services, Inc. (NYSE:PWR) announced today that it has been named the top solar infrastructure solutions provider in the United States by Solar Power World .
  • This achievement was made possible by the collaborative work of three Quanta operating companies: Blattner Company , RP Construction Services (RPCS) and The Ryan Company .
  • The combined expertise and efforts of the three companies installed more than two gigawatts of domestic solar generating capacity in 2022 alone – a new milestone of achievement in Top Solar Contractor history.
  • Duke Austin, Quanta Services' President and Chief Executive Officer said, "Being named Top Solar Contractor is an honor and tells part of the bigger story of how we are working to build a brighter and cleaner energy future for the country.

Thompson Street Capital Partner’s Vector Laboratories Acquires Quanta BioDesign

Retrieved on: 
Tuesday, July 25, 2023
Professional Services, Health, Apps, Applications, Technology, Finance, Pharmaceutical, Biotechnology, Quanta, Vector, Doctor of Philosophy, Click chemistry, Plain City, Caliper Life Sciences, Acquisition, TSCP, Drug discovery, Immunohistochemistry, Growth, Fine chemical

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Quanta BioDesign , the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications, by Vector Laboratories , a portfolio company of TSCP and the pioneer of innovative proteomic and glycomic research solutions.

Key Points: 
  • Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Quanta BioDesign , the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications, by Vector Laboratories , a portfolio company of TSCP and the pioneer of innovative proteomic and glycomic research solutions.
  • This acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences.
  • “This acquisition supports Vector Laboratories’ long-term strategic vision of accelerating the pace of scientific discovery for life science companies and transformational treatments and approaches for biopharma companies,” said Lisa V. Sellers, PhD, CEO of Vector Laboratories.
  • Vector was the first company to commercialize avidin-biotin enzyme complex kits for immunohistochemistry and antifade mounting media for immunofluorescence.

QUANTA SERVICES ANNOUNCES SECOND QUARTER 2023 EARNINGS RELEASE & CONFERENCE CALL SCHEDULE

Retrieved on: 
Tuesday, July 18, 2023
Webcast, PWR, Quanta Services, Conference, NYSE, Quanta

HOUSTON, July 18, 2023 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that it will release second quarter 2023 financial results on Thursday, August 3, 2023, before the market opens.

Key Points: 
  • HOUSTON, July 18, 2023 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that it will release second quarter 2023 financial results on Thursday, August 3, 2023, before the market opens.
  • In conjunction with the press release, Quanta has scheduled a conference call and webcast for 9:00 a.m. Eastern time on Thursday, August 3, 2023.
  • Live via phone – By dialing (201) 689-8345 or (877) 407-8291 and asking for the Quanta Services Second Quarter 2023 Earnings Conference Call at least 10 minutes prior to the start time.
  • For more information, please contact Kip Rupp at Quanta Services at (713) 341-7260.

Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers

Retrieved on: 
Monday, July 17, 2023
Biotechnology, FDA, Other Health, Health, General Health, Pharmaceutical, Oncology, Other Science, Research, Science, Clinical Trials, Quanta, Laboratory, Eye, Cancer, Doctor of Philosophy, Propylene glycol, Click chemistry, Plain City, Caliper Life Sciences, Acquisition, Drug discovery, Immunohistochemistry, Death, Pharmaceutical industry, Vector

This most recent acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences.

Key Points: 
  • This most recent acquisition further expands Vector Laboratories’ portfolio of bioconjugation linkers and dyes and builds on its manufacturing and bioconjugation capabilities to better serve partners across biopharma and the life sciences.
  • “This acquisition is valuable because it supports Vector Laboratories’ long-term strategic vision of accelerating the pace of scientific discovery for life science companies and transformational treatments and approaches for biopharma companies,” said Lisa V. Sellers , PhD, CEO of Vector Laboratories.
  • Quanta BioDesign was founded in 1997 by Paul D. Davis, PhD, in response to his wife’s death due to cancer.
  • Vector Laboratories was the first company to commercialize avidin-biotin enzyme complex kits for immunohistochemistry and antifade mounting media for immunofluorescence.

Global and China Automotive Electronics OEM/ODM/EMS Industry Report 2023: Amid the Evolution of E/E Architectures, the Boundary Between PCs and Vehicles will Gradually Vanish in the Zonal Era

Retrieved on: 
Monday, July 3, 2023
Quanta, ADM, Lens Technology, Pegatron, Yulon, Nokia, EV, MIH, Electronics, Original equipment manufacturer, Sunny Optical, BMW X3, HUD, Mercedes-Benz G-Class, Automotive Electronics Council, NIO, Lidar, Apollo, ODM, EMS, Motorola, Foxconn, ACU, Personal computer, Seres, CPU, CDMS, Quanta Computer, Apolong, JAC, Architecture, BOE, Baidu, OEM, Luxshare, AR, Software, Automotive industry, Video game, Mobile phone, Huawei, Wistron, Flex (company), Apple

Automotive electronics OEM/ODM/EMS: hardware OEM/ODM/EMS companies are transforming into integrated hardware solution providers, and accelerating in-depth cooperation with OEMs.

Key Points: 
  • Automotive electronics OEM/ODM/EMS: hardware OEM/ODM/EMS companies are transforming into integrated hardware solution providers, and accelerating in-depth cooperation with OEMs.
  • For example, suppliers of Apple such as Quanta Computer, Wistron, Pegatron and Luxshare Precision race to embark on automotive electronics OEM/ODM/EMS.
  • Amid the evolution of E/E architectures, the boundary between PCs and vehicles will gradually vanish in the zonal era.
  • Foxconn's CDMS (contract design and manufacturing service) business model is that Foxconn becomes a CDMS provider for the automotive industry.

AM Best Affirms Credit Ratings of Quanta Insurance Company, Inc.

Retrieved on: 
Thursday, June 29, 2023
Insurance, Professional Services, Quanta, AM Best, Quanta Services, ALL, Risk management, Credit, Orientation, QIC, AM, PWR, News, NYSE

For current Best’s Credit Ratings and independent data on the captive and alternative risk transfer insurance market, please visit www.ambest.com/captive .

Key Points: 
  • For current Best’s Credit Ratings and independent data on the captive and alternative risk transfer insurance market, please visit www.ambest.com/captive .
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.